The Reimbursement Report 2009
The second part of report summarizing the reimbursement situation in Poland in 2009 is now availabel. You will find inside:
- evaluation of transparency level of polish oncological drug reimbursement procedures in accordance to the transparency directive of public administration
- an analysis of institutions procedures which recommend drug financing from public funds
- recommendations of actions necessary to be taken in order to improve public administration regarding the reimbursement scope
